New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
13:12 EDTIBM, GOOG, CREE, AMD, ISRG, COH, DGX, MAPP, AGNOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday as the Dow was lifted by an advance in IBM (IBM) shares and the Nasdaq was similarly boosted by Google's (GOOG) outperformance. The S&P has been a laggard all morning, remaining near the flat line since the open, but is back in positive ground in afternoon trading... ECONOMIC EVENTS: In the U.S., the light economic calendar included the Home Price Index, which showed prices rose 0.6% in November, versus expectations for an increase of 0.7%. Also of note, the International Monetary Fund lowered its outlook for 2013 global output growth to 3.5% from 3.6%... COMPANY NEWS: IBM advanced over 5% at midday after its earnings report and guidance exceeded expectations. Google similarly reported earnings that beat consensus and price targets on its shares were raised all over The Street. Google advanced over 6% following the report... Among others reporting earnings last night and this morning, advancers included Cree (CREE), Advanced Micro Devices (AMD) and Intuitive Surgical (ISRG); decliners included Coach (COH) and Quest Diagnostics (DGX)... MAJOR MOVERS: Among the notable gainers not moving on earnings was MAP Pharmaceuticals (MAPP), which rose 58.6% to $24.71 after agreeing to be acquired by Allergan (AGN) for $25 per share. Allergan shares fell 1.2% following the announcement. Also lower were shares of Molycorp (MCP), which fell about 9% after disclosing it now sees Q4 and 1H13 production substantially lower than expected... INDICES: Near 1 pm ET, the Dow was up 67.87, or 0.49%, to 13,780.08; the Nasdaq was up 9.63, or 0.31%, to 3,152.81; and the S&P 500 was up 0.74, or 0.05%, to 1,493.30.
News For IBM;GOOG;CREE;AMD;ISRG;COH;DGX;MAPP;AGN From The Last 14 Days
Check below for free stories on IBM;GOOG;CREE;AMD;ISRG;COH;DGX;MAPP;AGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
August 19, 2014
17:14 EDTAGNOn The Fly: Closing Wrap
Subscribe for More Information
16:52 EDTAGNAllergan all-cash deal would reduce hostile bid chances, says BMO Capital
Subscribe for More Information
14:40 EDTAGNSterne Agee says Allergan could pay up to $190 for Salix and still be accretive
Subscribe for More Information
13:13 EDTAGNAllergan approached Salix, one other about takeover, WSJ reports
Subscribe for More Information
13:06 EDTAGNSalix jumps 6% to $147.85 after WSJ report of Allergan approach
Subscribe for More Information
13:05 EDTAGNAllergan approached Salix about takeover, WSJ reports
11:05 EDTIBMImperva seen as takeover candidate under new CEO
Subscribe for More Information
08:42 EDTIBMImperva new CEO has history of selling companies, says Sterne Agee
After Imperva (IMPV) appointed Anthony Bettencourt as its new CEO, Sterne Agee says that he has a history of selling companies. The firm believes that Imperva "would likely be an acquisition candidate" for a number of large tech companies such as Cisco (CSC), Juniper (JNPR), HP (HPQ), IBM (IBM), Check Point (CHKP), or F5 (FFIV). Sterne Agee believes that Imperva could be acquired for as much as $45 per share, and it keeps a Buy rating on the stock.
06:50 EDTGOOGImages show impending Google music subscription service, Android Police says
Subscribe for More Information
06:13 EDTGOOGContinental AG hires Google's Seval Oz to lead new division, WSJ reports
Subscribe for More Information
05:57 EDTGOOGGoogle to offer accounts to children under 13, WSJ reports
Subscribe for More Information
August 18, 2014
15:59 EDTAGNAllergan CFO change may suggest strategic deal near, says BMO Capital
BMO Capital believes former Allergan (AGN) CFO Jeff Edwards would not be leaving if a change of control of the company, such as a takeover by Valeant (VRX), were in the future. Rather, BMO thinks Edwards' decision to leave could be a sign that a strategic transaction marking a new chapter in Allergan's growth may be nearing. The firm thinks Allergan is in capable hands with new CFO Jim Hindman and it keeps an Outperform rating on the stock with a $230 price target.
13:12 EDTGOOGMicrosoft getting ready to launch Chromebook challengers, 9to5Google says
Subscribe for More Information
11:57 EDTAGNAllergan CFO departure largely unexpected, says Wells Fargo
Subscribe for More Information
10:57 EDTCREEOptions with decreasing implied volatility
Subscribe for More Information
10:29 EDTAMDGoldman cuts sector view on semiconductors to Cautious
Subscribe for More Information
09:02 EDTAGNAllergan names Jim Hindman as CFO, effective immediately
Subscribe for More Information
08:04 EDTAMDSemiconductors sector downgraded to Cautious from Neutral at Goldman
Goldman downgraded the Semiconductors sector to Cautious given signs the cycle is turning based on expectations for a slowdown in semiconductor revenue growth, above trend semi unit shipments that should normalize, and stretching lead times. As a result, the analyst sees risk to Q4 estimates and sees further downside of 10%-25% for the SOX (SOX) and downgraded NXP Semiconductors (NXPI) to Sell from Neutral, InvenSense (INVN) to Neutral from Buy, and removed Maxim Integrated (MXIM) from the Conviction Buy List.
07:57 EDTAGNCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
06:06 EDTCREECree implied volatility of 28 at lower end of index mean range
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use